Dr Solveigh Koeberle, a scientist at the Institute of Pharmaceutical Sciences / Pharmacognosy at the University of Graz, has been awarded funding to the Elise Richter Programme of the Austrian Science Fund (FWF) for the research project 'Redox regenerative agents in ferroptosis'. This renowned programme supports excellent female researchers on their way to a professorship and promotes innovative basic research. The project aims to develop novel therapeutic approaches for diseases associated with ferroptotic cell death. Ferroptosis is a distinct form of programmed cell death that plays a key role in the development of various degenerative diseases, including Alzheimer's, Parkinson's and fatty liver disease.
In previous studies, Dr Koeberle's research team identified several compounds with potent protective properties against cell death. The current project will focus on elucidating the mechanisms of action of these compounds and evaluating their efficacy in preclinical studies. Interdisciplinary collaboration is a key element of this project and Dr Koeberle will be working with researchers and experts from a range of disciplines to address the complex aspects of her research.
Dr Koeberle is looking forward to the challenges ahead: ‘With the results of our project, we hope to make significant progress in the fundamental understanding of ferroptosis and provide new impulses for the development of innovative therapies.’
Further information
Details of the project are available on the official FWF website: